Banned Weight-loss Drug Could Combat Liver Disease, Diabetes

sciencehabit writes: A drug the U.S. government once branded "extremely dangerous and not fit for human consumption" deserves a second chance, a study of rats suggests. Researchers report (abstract) that a slow-release version of the compound reverses diabetes and nonalcoholic fatty liver disease (NAFLD), an untreatable condition that can lead to cirrhosis and liver cancer.